RE:RE:RE:AGM in sept haha still derma injector hopes ;-) indeed does not look like Shiseido buys em out, hopefully we will find out this year. If that 's not the case they might get some money paid for damages... On the other hand why did Shiseido ran a 2nd trail if they see no value in the tec?!
The derma injector story is nothing of value from my point of view. Even if this device gets released, which I doubt, its nothing where you can expect a sudden huge demand and even more unlikly high profits.
Simply their hair loss therapy is where the potential is for a huge demand/profits, as it always has been. If this potential can't be translated into reality there is simply no value in Replicel.
Even the YOFOTO story looks like a dead end, seems the progress here is zero.
Hopefully the AGM date is the final one....